• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导多能干细胞在模拟血管疾病中平滑肌细胞功能方面的应用。

Application of induced pluripotent stem cells to model smooth muscle cell function in vascular diseases.

作者信息

Ji HaYeun, Kim Hye Sung, Kim Hae-Won, Leong Kam W

机构信息

Department of Biomedical Engineering, Columbia University, New York, NY, 10027, USA.

Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 330-714, South Korea.

出版信息

Curr Opin Biomed Eng. 2017 Mar;1:38-44. doi: 10.1016/j.cobme.2017.02.005. Epub 2017 Mar 22.

DOI:10.1016/j.cobme.2017.02.005
PMID:29082353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5654589/
Abstract

Vascular smooth muscle cells (SMC) play an essential role in remodeling the vasculature during disease progression. Induced pluripotent stem cells (iPSC) provide an attractive approach to obtain autologous SMC source for patient-specific disease modeling. Here we discuss the current methods to 1) derive functional SMC from iPSC, 2) model vascular diseases using SMC generated from patient-derived iPSC, and 3) modulate microenvironmental cues to enhance cellular differentiation and functionality and better mimic the physiological environment. We emphasize that continuous exploration of biomaterial technologies to engineer a more SMC-specific microenvironment will provide further insight on complex vascular diseases.

摘要

血管平滑肌细胞(SMC)在疾病进展过程中对血管重塑起着至关重要的作用。诱导多能干细胞(iPSC)为获取用于患者特异性疾病建模的自体SMC来源提供了一种有吸引力的方法。在这里,我们讨论当前的方法,即1)从iPSC中衍生出功能性SMC,2)使用从患者来源的iPSC生成的SMC对血管疾病进行建模,以及3)调节微环境线索以增强细胞分化和功能,并更好地模拟生理环境。我们强调,持续探索生物材料技术以构建更具SMC特异性的微环境将为复杂血管疾病提供进一步的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4060/5654589/00fd0217b75f/nihms873553f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4060/5654589/00fd0217b75f/nihms873553f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4060/5654589/00fd0217b75f/nihms873553f1.jpg

相似文献

1
Application of induced pluripotent stem cells to model smooth muscle cell function in vascular diseases.诱导多能干细胞在模拟血管疾病中平滑肌细胞功能方面的应用。
Curr Opin Biomed Eng. 2017 Mar;1:38-44. doi: 10.1016/j.cobme.2017.02.005. Epub 2017 Mar 22.
2
Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.诱导多能干细胞特性是否与体外平滑肌细胞高效分化相关?三种患者来源的诱导多能干细胞系的比较。
Stem Cells Dev. 2018 Oct 15;27(20):1438-1448. doi: 10.1089/scd.2018.0031. Epub 2018 Aug 28.
3
Deriving vascular smooth muscle cells from mesenchymal stromal cells: Evolving differentiation strategies and current understanding of their mechanisms.从间充质基质细胞中提取血管平滑肌细胞:不断发展的分化策略及对其机制的现有理解。
Biomaterials. 2017 Nov;145:9-22. doi: 10.1016/j.biomaterials.2017.08.028. Epub 2017 Aug 15.
4
Everolimus Rescues the Phenotype of Elastin Insufficiency in Patient Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.雷帕霉素挽救了源自弹性蛋白缺陷症患者诱导多能干细胞的血管平滑肌细胞的表型。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1325-1339. doi: 10.1161/ATVBAHA.119.313936. Epub 2020 Mar 26.
5
Smooth Muscle Precursor Cells Derived from Human Pluripotent Stem Cells for Treatment of Stress Urinary Incontinence.源自人多能干细胞的平滑肌前体细胞用于治疗压力性尿失禁
Stem Cells Dev. 2016 Mar 15;25(6):453-61. doi: 10.1089/scd.2015.0343.
6
Molecular regulation of vascular smooth muscle cell differentiation in development and disease.发育和疾病中血管平滑肌细胞分化的分子调控
Physiol Rev. 2004 Jul;84(3):767-801. doi: 10.1152/physrev.00041.2003.
7
Smooth Muscle Cell Phenotypic Diversity.平滑肌细胞表型多样性。
Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1715-1723. doi: 10.1161/ATVBAHA.119.312131. Epub 2019 Jul 25.
8
mESC-based in vitro differentiation models to study vascular response and functionality following genotoxic insults.基于小鼠胚胎干细胞的体外分化模型,用于研究遗传毒性损伤后的血管反应和功能。
Toxicol Sci. 2015 Mar;144(1):138-50. doi: 10.1093/toxsci/kfu264. Epub 2014 Dec 15.
9
Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.利用多能干细胞技术对人类神经退行性疾病进行逆向工程研究。
Brain Res. 2016 May 1;1638(Pt A):30-41. doi: 10.1016/j.brainres.2015.09.023. Epub 2015 Sep 28.
10
Human Pluripotent Stem Cell-Derived -Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.人多能干细胞衍生的单倍体不足平滑肌细胞概括了淋巴管平滑肌瘤病的特征。
Cancer Res. 2017 Oct 15;77(20):5491-5502. doi: 10.1158/0008-5472.CAN-17-0925. Epub 2017 Aug 22.

引用本文的文献

1
Bioengineered vascular grafts with a pathogenic variant model aneurysm formation in vivo and reveal underlying collagen defects.生物工程血管移植物在体内形成具有致病变异体模型的动脉瘤,并揭示了潜在的胶原缺陷。
Sci Transl Med. 2024 May 8;16(746):eadg6298. doi: 10.1126/scitranslmed.adg6298.
2
Comparative study of differentiating human pluripotent stem cells into vascular smooth muscle cells in hydrogel-based culture methods.基于水凝胶培养方法将人多能干细胞分化为血管平滑肌细胞的比较研究。
Regen Ther. 2022 Dec 21;22:39-49. doi: 10.1016/j.reth.2022.12.001. eCollection 2023 Mar.
3
Advances in Cardiac Tissue Engineering.

本文引用的文献

1
An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death.人诱导多能干细胞衍生的马凡综合征血管模型鉴定平滑肌细胞死亡的关键介质。
Nat Genet. 2017 Jan;49(1):97-109. doi: 10.1038/ng.3723. Epub 2016 Nov 28.
2
Tissue-Engineered Vascular Rings from Human iPSC-Derived Smooth Muscle Cells.人诱导多能干细胞衍生平滑肌细胞构建组织工程化血管环。
Stem Cell Reports. 2016 Jul 12;7(1):19-28. doi: 10.1016/j.stemcr.2016.05.004.
3
Implantable tissue-engineered blood vessels from human induced pluripotent stem cells.
心脏组织工程学进展
Bioengineering (Basel). 2022 Nov 16;9(11):696. doi: 10.3390/bioengineering9110696.
4
-Adventitial delivery of smooth muscle cells in porous collagen scaffolds for treatment of experimental abdominal aortic aneurysm.多孔胶原支架中平滑肌细胞的外膜递送用于治疗实验性腹主动脉瘤。
Biomater Sci. 2021 Oct 12;9(20):6903-6914. doi: 10.1039/d1bm00685a.
5
Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.人多能干细胞源性心脏基质细胞及其在再生医学中的应用。
Stem Cell Res. 2020 May;45:101831. doi: 10.1016/j.scr.2020.101831. Epub 2020 Apr 27.
6
Mechanical properties of stem cells from different sources during vascular smooth muscle cell differentiation.不同来源干细胞在血管平滑肌细胞分化过程中的力学特性。
Mol Cell Biomech. 2017;14(3):153-169. doi: 10.3970/mcb.2017.014.153.
7
Engineered Microenvironment for Manufacturing Human Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.用于制造人多能干细胞衍生的血管平滑肌细胞的工程化微环境。
Stem Cell Reports. 2019 Jan 8;12(1):84-97. doi: 10.1016/j.stemcr.2018.11.009. Epub 2018 Dec 6.
源自人类诱导多能干细胞的可植入组织工程血管
Biomaterials. 2016 Sep;102:120-9. doi: 10.1016/j.biomaterials.2016.06.010. Epub 2016 Jun 14.
4
Human Vascular Microphysiological System for in vitro Drug Screening.用于体外药物筛选的人体血管微生理系统。
Sci Rep. 2016 Feb 18;6:21579. doi: 10.1038/srep21579.
5
Defined three-dimensional microenvironments boost induction of pluripotency.定义的三维微环境促进多能性的诱导。
Nat Mater. 2016 Mar;15(3):344-52. doi: 10.1038/nmat4536. Epub 2016 Jan 11.
6
Scaffold-free, Human Mesenchymal Stem Cell-Based Tissue Engineered Blood Vessels.无支架、基于人间充质干细胞的组织工程血管
Sci Rep. 2015 Oct 12;5:15116. doi: 10.1038/srep15116.
7
NF-κB activation impairs somatic cell reprogramming in ageing.NF-κB 激活会损害衰老过程中的体细胞核重编程。
Nat Cell Biol. 2015 Aug;17(8):1004-13. doi: 10.1038/ncb3207. Epub 2015 Jul 27.
8
Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells.从人多能干细胞生成血管内皮细胞和平滑肌细胞。
Nat Cell Biol. 2015 Aug;17(8):994-1003. doi: 10.1038/ncb3205. Epub 2015 Jul 27.
9
Biomechanical strain induces elastin and collagen production in human pluripotent stem cell-derived vascular smooth muscle cells.生物力学应变可诱导人多能干细胞衍生的血管平滑肌细胞产生弹性蛋白和胶原蛋白。
Am J Physiol Cell Physiol. 2015 Aug 15;309(4):C271-81. doi: 10.1152/ajpcell.00366.2014. Epub 2015 Jun 24.
10
Marfan Sartan: a randomized, double-blind, placebo-controlled trial.马凡沙坦:一项随机、双盲、安慰剂对照试验。
Eur Heart J. 2015 Aug 21;36(32):2160-6. doi: 10.1093/eurheartj/ehv151. Epub 2015 May 2.